Keiichi Kumasawa Selected Research

Keiichi Kumasawa Research Topics

Disease

12	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2011
4	Neoplasms (Cancer) 04/2020 - 05/2013
4	Placenta Accreta 12/2017 - 12/2014
3	Hypoxia (Hypoxemia) 11/2021 - 01/2018
3	Choriocarcinoma 01/2018 - 11/2010
2	Infections 01/2022 - 12/2017
2	Fever (Fevers) 01/2022 - 12/2017
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Premature Birth (Birth, Premature) 08/2020 - 01/2020
2	Hemorrhage 07/2020 - 12/2014
2	Ovarian Neoplasms (Ovarian Cancer) 04/2020 - 05/2013
2	Oligospermia (Oligozoospermia) 01/2017 - 01/2017
2	Asthenozoospermia 01/2017 - 01/2017
1	Fetal Distress 05/2022
1	Hypertension (High Blood Pressure) 04/2022
1	Cysts 03/2022
1	Ascites 01/2022
1	Postpartum Hemorrhage 01/2022
1	Necrosis 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Oligohydramnios 01/2021
1	Fistula 01/2021
1	Intra-Abdominal Hypertension 07/2020
1	HELLP Syndrome 07/2020
1	Hematoma 07/2020
1	Maternal Obesity 01/2019
1	Fetal Death 01/2019
1	Ischemia 10/2018
1	Fibrosis (Cirrhosis) 10/2018
1	Disseminated Intravascular Coagulation 12/2017
1	Cicatrix (Scar) 02/2017
1	Hypercholesterolemia 01/2017
1	Hyperglycemia 01/2017
1	Hypertriglyceridemia 01/2017
1	Morbid Obesity 01/2017
1	Hyperphagia (Overeating) 01/2017
1	Disease Progression 12/2016
1	Placenta Previa 06/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2012

Drug/Important Bio-Agent (IBA)

4	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 01/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2011
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2019
2	LipopolysaccharidesIBA 01/2021 - 01/2020
2	Pravastatin (Pravachol)FDA LinkGeneric 08/2020 - 01/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2020 - 01/2011
2	Dacarbazine (DIC)FDA LinkGeneric 07/2020 - 12/2017
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2010
2	CytokinesIBA 01/2020 - 12/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2016
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 04/2022
1	Antihypertensive Agents (Antihypertensives)IBA 04/2022
1	Desmoplakins (Desmoplakin)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Histones (Histone)IBA 11/2021
1	Histone MethyltransferasesIBA 11/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Progesterone FDA LinkGeneric 01/2021
1	Therapeutic UsesIBA 08/2020
1	Carboplatin (JM8)FDA LinkGeneric 04/2020
1	MitogensIBA 01/2020
1	MAP Kinase Kinase Kinase 5IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	lysophosphatidic acidIBA 11/2019
1	EnzymesIBA 11/2019
1	Lysophosphatidic Acid ReceptorsIBA 11/2019
1	ArginaseIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	AnticoagulantsIBA 12/2017
1	Leptin ReceptorsIBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	ChylomicronsIBA 01/2017
1	Vardenafil Dihydrochloride (Levitra)FDA Link 10/2015
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 10/2015
1	Protective AgentsIBA 10/2015
1	Pharmaceutical PreparationsIBA 10/2015
1	Tissue Inhibitor of Metalloproteinase-2IBA 10/2013
1	Tumor Biomarkers (Tumor Markers)IBA 10/2013
1	IntegrinsIBA 05/2013
1	MicroRNAs (MicroRNA)IBA 05/2013
1	7- (4'- (2- nitroimidazole- 1- yl)butyl)theophyllineIBA 01/2012
1	Inosine Triphosphate (ITP)IBA 01/2012
1	Prostaglandins FIBA 01/2011
1	EndoglinIBA 01/2011
1	CalponinsIBA 11/2010

Therapy/Procedure

6	Therapeutics 08/2020 - 05/2013
5	Cesarean Section (Caesarean Section) 05/2022 - 06/2016
3	Conservative Treatment 05/2022 - 12/2016
2	Hysterectomy 01/2022 - 12/2014
1	Transjugular Intrahepatic Portasystemic Shunt 03/2022
1	Uterine Artery Embolization 01/2022
1	Catheters 01/2021
1	Drug Therapy (Chemotherapy) 04/2020
1	Heterologous Transplantation (Xenotransplantation) 10/2018
1	Tissue Transplantation 10/2018
1	Transplantation 10/2018
1	Uterine Myomectomy 06/2016